SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000921895-10-000216
Filing Date
2010-02-12
Accepted
2010-02-12 15:39:06
Documents
2

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO THE SCHEDULE 13G sc13ga107422gtx_12312009.htm SC 13G/A 231620
2 JOINT FILING AGREEMENT ex991to13ga107422gtx_123109.htm EX-99.1 31851
  Complete submission text file 0000921895-10-000216.txt   265430
Mailing Address 900 N. MICHIGAN AVENUE, SUITE 1100 CHICAGO IL 60611
Business Address 900 N. MICHIGAN AVENUE, SUITE 1100 CHICAGO IL 60611 3125066500
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 6282 Investment Advice

Mailing Address 175 TOYOTA PLAZA 7TH FLOOR MEMPHIS TN 38103
Business Address 175 TOYOTA PLAZA 7TH FLOOR MEMPHIS TN 38103 901-523-9700
GTX INC /DE/ (Subject) CIK: 0001260990 (see all company filings)

IRS No.: 621715807 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-79588 | Film No.: 10598792
SIC: 2834 Pharmaceutical Preparations